Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

AI Robot Massages Enter the Spa Scene, Challenging Traditional Therapists

by Team Lumida
July 14, 2025
in Health and Longevity
Reading Time: 4 mins read
A A
0
AI Robot Massages Enter the Spa Scene, Challenging Traditional Therapists
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  1. Emerging Technology: AI-powered robot massage machines, such as Aescape, are being introduced in hotels and spas, including the W Scottsdale, Four Seasons Resort Orlando, and Ritz-Carlton Bacara.
  2. Automated Experience: The robot massage offers an automated experience with customizable settings for pressure and music, controlled via an iPad-like device.
  3. Comparison to Human Massage: A direct comparison at the W Scottsdale revealed that while the robot provided relaxation and convenience (no oils, no check-out), it lacked the personalized touch and ability to address specific areas like the head and neck, which a human therapist could.
  4. Cost Difference: A 60-minute Aescape robot massage cost $120*, significantly less than a 50-minute traditional de-stress massage at $190* (or$228 with service charge).
  5. Target Audience: Hotel general managers suggest robot massages are not meant to replace human therapists but cater to those who prefer less personal interaction or need quick recovery sessions, such as athletes.

What Happened?

A new trend in the spa industry sees the introduction of AI-powered robot massage machines, exemplified by Aescape, now available in several high-end hotels and spas. A Wall Street Journal columnist experienced both a robot massage and a traditional human massage at the W Scottsdale to compare the two.

The robot massage offered an automated, customizable experience, but the columnist found it less effective for specific pain points and lacking the comprehensive touch of a human therapist. Despite the cost difference, the human massage was deemed superior for its personalized approach and ability to address all body areas.


Why It Matters?

The emergence of AI robot massages signifies the increasing integration of artificial intelligence into service industries, including wellness and hospitality. This trend presents both opportunities for efficiency and challenges to traditional service models.

While robot massages offer a more affordable and potentially less intrusive option for some, they highlight the enduring value of human touch, intuition, and personalized care in services like massage therapy. The comparison underscores that while AI can automate tasks, it may not fully replicate the nuanced experience provided by human professionals.


What’s Next?

The adoption of AI robot massages is likely to continue, particularly in settings where quick, customizable, and less expensive options are desired. However, human massage therapists are unlikely to be fully replaced, as their ability to provide tailored, empathetic, and comprehensive treatments remains a key differentiator.

The future of the spa industry may see a hybrid model, where both AI-powered and human-led services coexist, catering to diverse client preferences and needs.


Source
Previous Post

Nvidia CEO Jensen Huang Dismisses Concerns Over Chinese Military Use of US AI Chips

Next Post

Wall Street Unfazed by Trump’s 200% Pharma Tariffs Due to Extended Grace Period

Recommended For You

Sleep Is the Most Underrated Longevity Investment

by Team Lumida
3 hours ago
Sleep Paralysis Explained: The Science Behind Your Nightmares

Key takeaways Powered by lumidawealth.com Poor sleep is linked to higher risk of heart disease, diabetes, obesity, depression, and early mortality. Consistent sleep timing matters as much as total...

Read more

U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

by Team Lumida
1 day ago
U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

Key takeaways Powered by lumidawealth.com U.S. life expectancy rose to 79 years in 2024, the highest on record, up 0.6 years YoY Drug-overdose deaths fell more than 26%, the...

Read more

Longevity Hacks Go Data-Driven as Preventive Health Becomes a Scalable Growth Market

by Team Lumida
2 days ago
man running on road near grass field

Key takeaways Powered by lumidawealth.com Longevity is shifting from wellness trends to measurable, science-backed health optimization Simple behaviors like strength training, protein intake, sleep consistency, and fasting windows show...

Read more

Preventive Health and Aging Tech Emerge as the Next Major Growth Market

by Team Lumida
3 days ago
black and red cherries on white bowl

Key takeaways Powered by lumidawealth.com Longevity is moving from niche wellness to a core healthcare and investment theme, powered by aging demographics and tech-driven prevention Breakthroughs in early diagnostics,...

Read more

Cancer Survivors Face Growing Risk of Heart Damage from Life-Saving Treatments

by Team Lumida
1 week ago
Cancer Survivors Face Growing Risk of Heart Damage from Life-Saving Treatments

Key Takeaways Powered by lumidawealth.com Advances in cancer treatments are leading to more survivors, but many face delayed heart damage from therapies. Modern treatments like immune checkpoint inhibitors and...

Read more

Sleep Regularity Is the Longevity Edge Most People Ignore

by Team Lumida
1 week ago
woman sleeping on bed under blankets

Key takeaways Powered by lumidawealth.com Sleep regularity (same bedtime/wake time) often matters as much as total hours for metabolic and cardiovascular health. Big swings in sleep timing can impair...

Read more

Longevity Moves From Lifestyle Trend to Investable Theme as Aging Demographics Drive Demand

by Team Lumida
1 week ago
diagram

Key takeaways Powered by lumidawealth.com Aging demographics are accelerating demand for therapies and services that extend healthspan, not just lifespan. Capital is shifting from reactive care to prevention, chronic-disease...

Read more

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

by Team Lumida
1 week ago
Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Key takeaways Powered by lumidawealth.com Metformin is a low-cost, widely prescribed diabetes drug being studied for whether it can delay age-related disease beyond glucose control. The core debate: strong...

Read more

Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

by Team Lumida
2 weeks ago
Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

Key takeaways Powered by lumidawealth.com Rapamycin (sirolimus) has some of the strongest preclinical longevity evidence, but human data is still early and fragmented. The core investment challenge is translation...

Read more

GLP-1s Are Becoming the First “Longevity Drug” With Real-World Outcomes Data

by Team Lumida
2 weeks ago
GLP-1s Are Becoming the First “Longevity Drug” With Real-World Outcomes Data

Key takeaways Powered by lumidawealth.com GLP-1 drugs are shifting from “weight-loss meds” to risk-reduction platforms, with evidence supporting meaningful improvements in cardiometabolic outcomes in obese/overweight populations. The investable story...

Read more
Next Post
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Wall Street Unfazed by Trump’s 200% Pharma Tariffs Due to Extended Grace Period

a black square with a blue logo on it

Meta to Build Gigawatt-Scale Data Centers for AI Superintelligence, Pentagon Awards AI Contracts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

silver and gold round coins

Bitcoin Bounces Back but Faces $7B Selling Pressure

July 10, 2024
a bitcoin sitting on top of a pile of money

US Stablecoin Dream Is a Nightmare for China

October 9, 2025
China’s Bold Economic Moves: What You Need to Know Now

China’s Manufacturing Activity Contracts in July as New Orders Weaken

August 1, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018